[1] KAPLAN S A. Benign prostatic hyperplasia[J]. J Urol,2021,205(5):1490-1492.
[2] MANOV J J,MOHAN P P,KAVA B,et al. Benign prostatic hyperplasia:a brief overview of pathogenesis,diagnosis,and current state of therapy[J]. Tech Vasc Interv Radiol,2020,23(3):100687.
[3] EID B G,ABDEL-NAIM A B. Piceatannol attenuates testosterone-induced benign prostatic hyperplasia in rats by modulation of Nrf2/HO-1/NFκB axis[J]. Front Pharmacol,2020,11:614897.
[4] STROPE S A. Evidence-based guidelines in lower urinary tract symptoms secondary to benign prostatic hyperplasia and variation in care[J]. Curr Opin Urol,2018,28(3):262-266.
[5] REN R M,KOU M,LAN X X. Efficacy and safety of tamsulosin for the treatment of benign prostatic hyperplasia:a meta analysis[J]. Chin Med J(Engl),2010,123(2):234-238.
[6] 郭俊,杜冠潮,赵丰,等. 基于VOSviewer与CiteSpace的良性前列腺增生中医药研究现状与趋势的知识图谱分析[J].世界科学技术-中医药现代化,2021,23(6):1902-1908.
[7] 李杰,魏永进,宋光烨,等. 前列腺疾病的中医体质研究进展[J].中国当代医药,2021,28(4):23-26.
[8] 黄丽平,许远航,邓敏贞,等. 茵陈的化学成分、药理作用机制与临床应用研究进展[J].天然产物研究与开发,2021,33(4):676-690.
[9] 贾照志. 茵陈蒿的化学成分,药理作用及临床应用进展[J].牡丹江医学院学报,2010,31(3):87-89.
[10] 李慧峰,孟霜,王鑫鑫,等. 基于网络药理学及实验验证探讨复方茴芹颗粒治疗前列腺增生的作用机制[J].中成药,2022,44(9):3041-3047.
[11] GONG Y M,WANG X,LIU S,et al. Simvastatin inhibits prostatic hyperplasia in rats with metabolic syndrome[J].Int Urol Nephrol,2022,54(9):2125-2131.
[12] ROSSI A,BRAGONZI A,MEDEDE M,et al. β-sitosterol ameliorates inflammation and pseudomonas aeruginosa lung infection in a mouse model[J]. J Cyst Fibros,2023,22(1):156-160.
[13] WANG X,ZHU J,YAN H,et al. Kaempferol inhibits benign prostatic hyperplasia by resisting the action of androgen[J]. Eur J Pharmacol,2021,907:174251.
[14] KHAN S,SHEHZAD O,CHUN J,et al. Anti-hyperalgesic and anti-allodynic activities of capillarisin via suppression of inflammatory signaling in animal model[J]. J Ethnopharmacol,2014,152(3):478-486.
[15] JANG E,KIM S Y,LEE N R,et al. Evaluation of antitumor activity of artemisia capillaris extract against hepatocellular carcinoma through the inhibition of IL-6/STAT3 signaling axis[J].Oncol Rep,2017,37(1):526-532.
[16] 胡黄金,雷利娟,郑靓怡,等. 升降通癃方中空栓对前列腺增生大鼠模型的影响[J].环球中医药,2022,15(9):1523-1528.
[17] VICKMAN R E,AARON-BROOKS L,ZHANG R,et al. TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease[J]. Nat Commun,2022,13(1):2133.
[18] LEE H H,PARK C,JEONG J W,et al. Apoptosis induction of human prostate carcinoma cells by cordycepin through reactive oxygen species mediated mitochondrial death pathway[J]. Int J Oncol,2013,42(3):1036-1044.
[1]马阔,韩广业,李泽宇,等.基于网络药理学及分子对接探讨金钱草治疗良性前列腺增生症的作用机制[J].天津医科大学学报,2025,31(02):105.
MA Kuo,HAN Guangye,LI Zeyu,et al.Exploring the mechanism of the treatment of benign prostatic hyperplasia by Lysimachia christinae using network pharmacology and molecular docking[J].Journal of Tianjin Medical University,2025,31(06):105.